BioStem Technologies, Inc.
NASDAQ:BSEMBiotechnology
-$0.21 today
- Market cap
- $52.14M
- Beta
- 0.26
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$1.63
Volume 0.09M
Average 0.07M
BSEM Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
BioStem Technologies, Inc.NASDAQ: BSEM
Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026
Weighted avg shares (diluted) declines year over year
Q2 FY2026 weighted avg shares (diluted) of 17.33M shares fell 30.0% year over year, behind the -21.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 2.8% from the prior quarter. Over 3 fiscal years it compounded at +13.6% a year.
Context
- Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -30.0% toward the trailing-twelve-month pace of -21.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 16.73M USD
- Year-over-year change
- -22.9%
- 4-year CAGR
- +9.4%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.73M | -22.9% |
| FY2024 | 2024-12-31 | 21.7M | +58.3% |
| FY2023 | 2023-12-31 | 13.71M | +20.2% |
| FY2022 | 2022-12-31 | 11.41M | -2.4% |
| FY2021 | 2021-12-31 | 11.69M | — |
Weighted Avg Shares (Diluted) vs competitors
How BSEM compares with its peers on the latest reported figures
No competitor Weighted Avg Shares (Diluted) figures are available to compare.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.34M | 6.88M | 16.69M | 301.83M | 47.48M |
| Cost of Revenue | 1.47M | 881.75K | 1.26M | 13.75M | 3.26M |
| Gross Profit | 2.87M | 5.99M | 15.42M | 287.86M | 44.22M |
| Gross Margin | 66.0% | 87.2% | 92.4% | 95.4% | 93.1% |
| Research & Development | 119.65K | 123.31K | 342K | 1.91M | 7.09M |
| Selling, General & Admin | 4.19M | 10.21M | 22.63M | 254.75M | 37.82M |
| Operating Expenses | 4.47M | 10.67M | 23.2M | 256.66M | 44.91M |
| Depreciation & Amortization | 283.9K | 243.42K | 229.02K | 293.22K | 219.42K |
| EBITDA | (602K) | (6.52M) | (7.55M) | 31.49M | (469.73K) |
| EBITDA Margin | -13.9% | -94.8% | -45.3% | 10.4% | -1.0% |
| Operating Income | (1.61M) | (4.68M) | (7.78M) | 31.2M | (689.15K) |
| Operating Margin | -37.0% | -68.1% | -46.6% | 10.3% | -1.5% |
| Interest Income | 0 | 0 | 0 | 0 | 413.85K |
| Interest Expense | 525.88K | 468.15K | 700.33K | 587.22K | 0 |
| Other Income / Expenses | 193.93K | (2.55M) | (704.02K) | (587.22K) | 299.5K |
| Income Before Tax | (1.41M) | (7.11M) | (8.48M) | 30.61M | (389.65K) |
| Pre-Tax Margin | -32.5% | -103.5% | -50.8% | 10.1% | -0.8% |
| Income Tax Expense | 0 | 0 | 0 | (1.27M) | 6.19M |
| Net Income | (1.45M) | (7.07M) | (8.48M) | 31.88M | (6.58M) |
| Net Margin | -33.3% | -102.9% | -50.8% | 10.6% | -13.9% |
| EPS (Basic) | (0.12) | (0.62) | (0.62) | 1.95 | (0.39) |
| EPS (Diluted) | (0.12) | (0.62) | (0.62) | 1.47 | (0.39) |
| Weighted Avg Shares | 11.69M | 11.41M | 13.71M | 16.37M | 16.73M |
| Weighted Avg Shares (Diluted) | 11.69M | 11.41M | 13.71M | 21.7M | 16.73M |
BioStem Technologies, Inc.
NASDAQ:BSEM
Intrinsic Alpha fair value
Locked
Current Price
$3.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.